Week in review: California radiologist arrested | Breast MRI downgrades BI-RADS 3 lesions | The promise of FAPI-PET

Dear AuntMinnie Member,

Our most-viewed article this week covered the sad story of a California radiologist arrested on suspicion of attempted murder and child abuse after driving a Tesla sedan -- with his wife and two young children inside -- over a Northern California cliff.

Dr. Dharmesh Patel, 42, of Los Angeles will be booked into the San Mateo County Jail as soon as he is released from the hospital, according to our report.

On a more uplifting note, our second most popular article features tips for radiology practices participating in the U.S. Centers for Medicare and Medicaid Services' Quality Payment Program. Erin Stephens of Healthcare Administrative Partners discussed the strategy in a new column.

More than 75% of radiologists indicate that they experience musculoskeletal discomfort from using their workstations. Fortunately, there are at least eight ways to mitigate this problem, according to a recent study.

You can find these and other stories on practice management topics in our Imaging Leaders Community.

Breast MRI downgrades BI-RADS 3 lesions

A new study has found that breast MRI could enable approximately 10% of breast lesions identified as BI-RADS 3 on ultrasound to be downgraded. MRI also agreed with the breast ultrasound results in 87% of cases and upgraded four cases to BI-RADS 4. What's more, the MRI evaluation also revealed two other deep lesions that had been missed on ultrasound. Click here to learn more.

In other articles this week in the Women's Imaging Community, artificial intelligence-based analysis of ultrasound images and videos was found to yield more accurate gestational age predictions than conventional fetal biometry techniques. You can get all of the details here.

The promise of FAPI-PET

Tumor detection in cancer patients can be improved by using gallium-68 fibroblast activation protein inhibitor (FAPI) PET imaging instead of conventional imaging, according to researchers from Germany. They believe the technique is a promising imaging modality that offers the potential for more precise staging and management in patients with sarcoma, pancreatic carcinoma, and primary brain tumors.

Another story in our Molecular Imaging Community generating significant page views highlighted the benefits of the F-18 fluciclovine radiotracer for helping to distinguish between pseudoprogression and actual tumor progression in patients with brain tumors.

Page 1 of 1158
Next Page